Anti-inflammatory and relaxatory effects of prostaglandin E2 in myometrial smooth muscle.
The onset of human labour is complex and involves multiple mediators, prostaglandins, cytokines and chemokines. However, whilst prostaglandins are routinely used for labour induction and inhibitors of prostaglandin synthesis are used to prevent pre-term labour, these practices are not invariably successful, and the rationale for their use is equivocal. As COX-2 and prostaglandin E(2) (PGE(2)) production is increased towards term, we have investigated the effect of PGE(2) and other cAMP-elevating agents on events associated with labour induction. Time-dependent increases in granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-8 (IL-8) release were observed following treatment of primary human myometrial smooth muscle (HMSM) cells with IL-1beta, via mechanisms that required de novo transcription and translation. Prior treatment with PGE(2) (1 microM) produced 86 and 80% decreases in GM-CSF and IL-8 release, respectively. Similarly, the cAMP analogue, 8-bromo-cAMP (8Br-cAMP) and the phosphodiesterase-4 (PDE(4)) inhibitor, rolipram, also repressed GM-CSF and IL-8 release. In addition, PGE(2), 8Br-cAMP, rolipram and salbutamol all had a dose-dependent inhibitory effect on spontaneous myometrial contractions in vitro. In this study, PGE(2) reduced the release of factors associated with cervical ripening and attenuated force development in myometrial smooth muscle, raising the possibility that in myometrium, PGE(2) may act to down-regulate some of the processes that contribute to the onset of human labour and may be beneficial in helping to maintain pregnancy towards term.
Slater
Donna M
DM
Department of Biological Sciences, Biomedical Research Institute, University of Warwick, Coventry, UK.
Astle
Shirley
S
Woodcock
Nicola
N
Chivers
Joanna E
JE
de Wit
Norbert C J
NC
Thornton
Steven
S
Vatish
Manu
M
Newton
Robert
R
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism*; D015232:Dinoprostone / Q000502:physiology*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000096:biosynthesis; D006801:Humans; D007375:Interleukin-1 / Q000502:physiology; D016209:Interleukin-8 / Q000096:biosynthesis; D009126:Muscle Relaxation / Q000502:physiology; D009130:Muscle, Smooth / Q000378:metabolism* / Q000502:physiology; D009215:Myometrium / Q000378:metabolism* / Q000502:physiology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007375:Interleukin-1; D016209:Interleukin-8; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D015232:Dinoprostone